Food and Drug Administration
-
With FDA Decision Looming, Plymouth Meeting’s Inovio Cuts Workforce to Preserve Cash
Over the past year, Plymouth Meeting-based Inovio Pharmaceuticals has reduced its workforce by 16 percent to preserve cash as it waits for the Food and…
-
Are Artificial Sweeteners Safe for Kids? What Parents Should Know
The American Academy of Pediatrics recommends kids ages two to 18 consume about six teaspoons of sugar per day. According to most sources, kids in…
-
Wayne-Based Palvella Shares Soar as Lead Drug Candidate Meets Trial Goals
Wayne-based Palvella Therapeutics stock jumped 35 percent following the announcement of positive late-stage testing for Qtorin rapamycin, its lead drug candidate for a rare skin disease, writes John George for the Philadelphia…
-
Malvern-Based Toetal Solutions Positions For Strategic Sale After FDA Clearance
Malvern-based Toetal Solutions is seeking a buyer after the Food and Drug Administration approved its hammertoe treatment system, writes John George for the Philadelphia Business Journal. …
-
Malvern-Based Galera Therapeutics Sells Drug Portfolio for Up to $105 Million
Following an FDA setback, Malvern-based Galera Therapeutics is selling its drug portfolio to the Canadian biotechnology firm Biossil in a deal that has been valued…
-
Malvern-Based Aevumed Leverages 3D Printing and AI to Develop Device for Joint Healing
Started by Saif Khalil in 2019, Malvern-based Aevumed leverages 3D printing and artificial intelligence to accelerate joint healing, writes Holly Quinn for Technical.ly. Khalil, who…
-
West Chester-Based Verrica Gets Medication Approval in Japan, Triggering $10M Milestone Payment
The regulatory approval of Verrica Pharmaceuticals‘ Ycanth in Japan has triggered a $10 million milestone payment to the West Chester-based company by its overseas partner,…
-
Malvern-Based Venatorx Enters Global Deal with Switzerland Pharma Company
Malvern-based Venatorx has entered into a global licensing deal for its experimental antibiotic for complicated urinary tract infections with Switzerland’s Basilea Pharmaceutica, writes John George…
-
Conshohocken’s ActiveProtective Launches Tango Belt, Eyes Nationwide Expansion
Conshohocken-based ActiveProtective has launched the Tango Belt, a fall prevention device that has been approved by the Food and Drug Administration, writes John George for…
-
West Chester-based Verrica Pharmaceuticals Agreement Has Potential for $18 Million Boost
West Chester-based Verrica Pharmaceuticals has amended its licensing agreement with Torii Pharmaceutical of Japan, potentially resulting in an $18 million boost in 2025, writes John…
-
Personal Tragedy Led Exton’s Kensey Nash Founder to New Role as Lungpacer Medical CEO
Personal tragedy led Doug Evans, founder of Exton-based Kensey Nash, to change his business trajectory and become CEO of Vancouver-based Lungpacer Medical, writes Brian Gormley…
-
Malvern-Based Ocugen to Pursue Rare Pediatric Disease Therapy
Malvern-based Ocugen has been granted rare pediatric disease designation by the Food and Drug Administration for its experimental gene therapy targeting Stargardt disease, writes John…
-
Malvern Medical Manufacturer Cleared for First-of-Its-Kind Alzheimer’s Blood Test
A first-of-its-kind blood test developed by Malvern-based Fujirebio Diagnostics to help diagnose Alzheimer’s disease has received clearance from the U.S. Food and Drug Administration, writes…
-
To Prep for First Product Launch, Exton’s Lungpacer Medical Doubles Workforce
Lungpacer Medical, headquartered in Canada with main operations in Exton, is raising funds and nearly doubling its workforce to support the commercial launch of its…
-
West Chester-based Verrica Pharmaceuticals Expects to Raise $42 Million in Public Stock Offering
West Chester-based Verrica Pharmaceuticals expects to raise $42 million in a public stock offering, following staff reductions and the appointment of a new CEO, writes…
-
West Chester-Based Verrica Pharmaceuticals Restructures to Expand Access for Flagship Product
Verrica Pharmaceuticals is restructuring its sales and operating teams in an effort to reduce costs and expand access to its flagship product, writes John George…
-
Chester Springs Woman One of Nation’s First Patients for Alzheimer’s Treatment
Karen Chung of Chester Springs has received one of the nation’s first treatments for early symptomatic Alzheimer’s disease, write Yukare Nakayama and Cherise Lynch for NBC10…
-
One Year After FDA Rejects Its Lead Candidate, Malvern-based Galera Therapeutics Moves to Dissolve
Malvern-based Galera Therapeutics is moving forward with a plan to shut down the company and liquidate all of its assets, writes John George for the…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
